First Follow-Up of Cardiac Amyloidosis Treated by Tafamidis, Evaluated by Absolute Quantification in Bone Scintigraphy.

Bellevre, Dimitri; Bailliez, Alban; Maréchaux, Sylvestre; Manrique, Alain; Mouquet, Frédéric

First Follow-Up of Cardiac Amyloidosis Treated by Tafamidis, Evaluated by Absolute Quantification in Bone Scintigraphy.

Bellevre, Dimitri; Bailliez, Alban; Maréchaux, Sylvestre; Manrique, Alain; Mouquet, Frédéric.

Afiliação

Bellevre D; Department of Cardiology, Normandy University, Caen, France.
Bailliez A; Department of Nuclear Medicine, Lille Catholic Institute Hospital Group, Lomme, France.
Maréchaux S; Department of Nuclear Medicine, Le Bois Private Hospital, Lille, France.
Manrique A; Department of Nuclear Medicine, Lille Catholic Institute Hospital Group, Lomme, France.
Mouquet F; Department of Nuclear Medicine, Le Bois Private Hospital, Lille, France.

JACC Case Rep ; 3(1): 133-135, 2021 Jan.

Article em En | MEDLINE | ID: mdl-34317486

Palavras-chave

ATTR, transthyretin-related [amyloidosis]; HMDP-99mTc, hydroxydimethylene diphosphonatetechnetium-99m; IVS, interventricular septum; LVEF, left ventricular ejection fraction; NT-ProBNP, N-terminal proB-type natriuretic peptide; NYHA, New York Heart Association; SPECT, single-photon emission computed tomography; SUV, standardized uptake value; SUVmax, maximum standardized uptake value; chronic heart failure; hybrid imaging; treatment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: JACC Case Rep Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: JACC Case Rep Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França